Global Ganja Report

A new survey by the UN Office on Drugs and Crime (UNODC) indicates that the value of opium in Afghanistan soared by 133% in 2011 over the previous year, netting farmers $1.4 billion. A blight last year wiped out much of the poppy yield, driving up prices. Yields have now returned to pre-blight levels—a 61% increase, from 3,600 tons in 2010 to 5,800 tons last year. But prices remain high, and UNODC says a simultaneous drop in the price of wheat contributed to the increase in poppy cultivation. Gross income from opium in 2011 was 11 times higher than that earned from wheat—the biggest difference in income since 2003. Afghanistan currently supplies an estimated 90% of the world's opium, with the largest areas of poppy cultivation in the country's restive south. (VOA, Jan. 13)

Colorado US Attorney John Walsh on Jan. 12 issued an ultimatum in letters to 23 dispensaries and landlords he claimed are in violation of federal and state law. The dispensaries, which he said are located within 1,000 feet of schools, were given 45 days to cease operations or face civil and criminal penalties. "When the voters of Colorado passed the limited medical marijuana amendment in 2000, they could not have anticipated that their vote would be used to justify large marijuana stores located within blocks of our schools," Walsh said in a statement announcing the letters. 

Officials in Mendocino County revealed Jan. 11 that the US Attorney's Office in San Francisco had threatened to sue the county over its medical marijuana cultivation permit program, prompting its suspension. The warning was delivered at a Jan. 3 meeting between County Counsel Jeanine Nadel and representatives of the US Attorney's Office, Nadel said. County supervisors are scheduled to review the permit ordinance on Jan. 24. The program was also suspended pending the outcome of a Southern California court case that tests the legitimacy of issuing permits for cannabis-related endeavors—the reason given by officials at the time of the suspension on Jan 9.

Ricardo Soberón, the anti-drug chief who last year briefly suspended coca eradication in Peru, resigned under pressure from the administration of President Ollanta Humala Jan. 10. The Council of Ministers (cabinet) appointed Carmen Masías Claux, a psychologist who is an advocate of eradication, to replace Soberón as head of the National Commission for Development and Life without Drugs (DEVIDA). The Council of Ministers is now led by the man who was interior minister at the time of Soberón's suspension of the program, Oscar Valdes—who publicly disagreed with the suspension, and ordered the program's resumption within a week.

Mendocino County's unique income-generating medical marijuana cultivation permit process has been suspended, officials announced Jan. 9. The decision was made in light of a Southern California court case that challenges the legality of issuing permits for activities that are illegal under federal law.

Moderate cannabis use appears to cause no long-term damage to the lungs, according to a new study by the University of California at San Francisco and the University of Alabama at Birmingham, released Jan. 10 in the Journal of the American Medical Association. Results of the 20-year study, funded by the National Institute on Drug Abuse, indicate that cannabis doesn't do the kind of damage tobacco does.

Long the main gateway to Europe for Moroccan hashish, Spain has over the past year emerged as one of the continent's main cannabis cultivation hubs, rivaling the Netherlands. Principal cultivation zones are Andalusia, Murcia, Catalonia, Aragon and especially Valencia—which the Guardia Civil describes as "a jungle of cannabis."

A British study discounts a link between occasional cannabis smoking or other light illicit drug use and the decline in mental functions that comes with middle age. The study, carried in the American Journal of Epidemiology, tested the mental function and memory of nearly 9,000 Britons at age 50 and found that those who had used illegal drugs as recently as in their 40s did just as well on the tests as peers who had never used drugs—or slightly better.